PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages duringchronic hepatitis C virus infection-Reference-Cited by-同舟云学术

PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages duringchronic hepatitis C virus infection

Published:2010-11-23 Issue:3 Volume:132 Page:421-431
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:

Author:

Ma Cheng J.,Ni Lei,Zhang Ying,Zhang C.L.,Wu Xiao Y.,Atia Antwan N.,Thayer Penny,Moorman Jonathan P.,Yao Zhi Q.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2010.03382.x/fullpdf

Reference39 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Adaptive immune responses in acute and chronic hepatitis C virus infection;Bowen;Nature,2005

3. Analysis of successful immune responses in persons infected with hepatitis C virus;Lechner;J Exp Med,2000

4. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection;Rehermann;J Clin Invest,1996

5. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection;Wedemeyer;J Immunol,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β1 induces PD-1 expression in macrophages through SMAD3/STAT3 cooperative signaling in chronic inflammation;JCI Insight;2024-03-05

2. PD‐1: A critical player and target for immune normalization;Immunology;2024-01-25

3. Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications;American Journal of Physiology-Heart and Circulatory Physiology;2023-10-01

4. PD-1 negatively tunes macrophage immune activation by turning off JNK and STAT1 signaling: Exploited by Leishmania for its intra-macrophage survival;Cellular Immunology;2023-09

5. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma;JCI Insight;2023-07-10